GlassScriptPhysician profile
Dzu Q Tran
NPI 1821025032
$771.11
in general payments reported to CMS, 2019-2025
16 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $90.27 · 2021: $136 · 2022: $47.46 · 2023: $27.65 · 2024: $153 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $216.01 | 2024-2025 | Evenity, Prolia, Repatha |
| Abbvie INC. | $204.27 | 2019-2023 | Lo Loestrin Fe |
| Covidien LP | $74.26 | 2019 | |
| Aspira Women'S Health INC | $50.51 | 2021 | |
| Myovant Sciences INC. | $29.08 | 2021 | |
| Coopersurgical, INC. | $25.03 | 2019-2020 | |
| Daiichi Sankyo INC. | $24.44 | 2020 | |
| Phathom Pharmaceuticals, INC. | $24.28 | 2025 | Voquezna |
| Agile Therapeutics, INC. | $21.15 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $18.32 | 2025 | Breztri |
| Pfizer INC. | $17.41 | 2021 | |
| Genentech USA, INC. | $14.62 | 2020 | |
| Amarin Pharma, INC. | $14.17 | 2020 | |
| Avion Pharmaceuticals | $12.86 | 2020 | |
| Mylan Pharmaceuticals INC. | $12.76 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $11.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dzu Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.